Southeast Ontario Neurofeedback Research
Neurofeedback Research is a cutting edge technology with a variety of clinical applications.
Our lab is studying how to best use neurofeedback to manage symptoms in people with long COVID. Future studies will explore use of neurofeedback for migraines, chronic pain, concussions, anxiety, depression, cancer and schizophrenia.
Join a study for people with long COVID experiencing cognitive impairment, such as memory or concentration problems or fatigue.
Have you had a confirmed COVID-19 infection more than 3 months ago and are now experiencing problems with memory or concentration or fatigue? Then you are invited to participate in a research study at Queen’s University to evaluate the effectiveness of using EEG-technology using neurofeedback brain training on cognitive problems or fatigue in people with long COVID.
About Neurofeedback Research
Neurofeedback is a non-invasive, drug-free form of brain training that helps the brain to achieve a calmer, more focused state much like the effects of meditation. Neurofeedback is reported to help with a variety of symptoms and conditions such as fatigue, anxiety, depressive symptoms, sleep problems and cognitive problems.
Southeast Ontario Neurofeedback Research Partners
Latest Resources and Research
Read about the latest research findings supporting the use of neurofeedback for a variety of clinical conditions. Find resources about neurofeedback .
Using Neurofeedback to Manage Long-Term Symptoms in Cancer Survivors: Results of a Survey of Neurofeedback Providers
Some cancer survivors are turning to a variety of neurofeedback types/protocols to successfully manage their long-term symptoms. Preliminary results suggest neurofeedback may be a safe and effective therapy for cancer survivors.
Exploring the Impact of Nonlinear Dynamical Neurofeedback on Post-Cancer Cognitive Impairment and Cancer-Related Fatigue: Results of Interviews with Breast Cancer Survivors
Results of this qualitative descriptive study suggest that nonlinear dynamical neurofeedback had a dramatic and meaningful positive effect on persistent symptoms experienced by breast cancer survivors, without any negative side effects. Participants in our sample found the neurofeedback sessions to be enjoyable and rec- ommend that they be offered to all cancer patients. Clinical trials with larger sample sizes are needed to corrob- orate our findings. Establishing clinical effectiveness could encourage adoption of neurofeedback into routine cancer care and health insurance coverage.
Exploring the effect of neurofeedback on postcancer cognitive impairment and fatigue: A pilot feasibility study
The neurofeedback protocol was feasible and resulted in significant decreases in perceived cognitive deficits, fatigue, sleep, and psychological symptoms.
The Effect of EEG Biofeedback on Reducing Postcancer Cognitive Impairment
Data from this limited study suggest that EEG biofeedback has potential for reducing the negative cognitive and emotional sequelae of cancer treatment as well as improving fatigue and sleep patterns.
About NeurOptimal® Neurofeedback
NeurOptimal® is an advanced neurotechnology designed to train the brain to function at peak performance levels. This innovative form of neurofeedback is not a medical treatment, but rather a training for the brain.
